China’s ZhenFund, together with HOF Capital, led an $11-million round for biotech firm Meliora Therapeutics while Hong Kong-headquartered insurtech firm YAS MicroInsurance snapped $4.5 million in a pre-Series A funding round.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
